On Monday November 17th a Parliamentary Reception was held to share the latest results from the Risk-sharing Scheme (RSS) for MS drugs.

Source MS Trust:
As the administrator for the RSS the MS Trust has worked for the last 12 years with the five parties to the Scheme namely the Department of Health, Biogen Idec, Bayer, Merck Serono and Teva to collect ongoing clinical data from 5,610 people with MS across the UK. Read on.